Metaanalysis of the Effect of Antenatal Indomethacin on Neonatal Outcomes

Overview

Journal Am J Obstet Gynecol

Publisher Elsevier

Specialty Gynecology & Obstetrics

Date 2007 Nov 6

PMID 17980183

Citations 14

Authors

Sanjiv B Amin

Robert A Sinkin

J Christopher Glantz

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of the study was to determine whether indomethacin used as a tocolytic agent is associated with adverse neonatal outcomes.

Study Design: We used published guidelines of the Metaanalysis of Observational Studies in Epidemiology Group (MOOSE) to perform the metaanalysis. The search strategy used included computerized bibliographic searches of MEDLINE (1966-2005), PubMed (1966-2005), abstracts published in Obstetrics and Gynecology (1991-2005), abstracts published in Pediatric Research (1991-2005), and references of published manuscripts. Study inclusion criteria were publication in English, more than 30 deliveries less than 37 weeks' gestation, and meeting diagnostic criteria for individual neonatal outcomes. Exclusion criteria included case reports, case series, and multiple publications from the same author. Metaanalysis was performed using random effects model if there were more than 2 observational studies for a specific outcome. Eggers test was performed to exclude publication bias. Sensitivity analysis was performed to evaluate the effect of antenatal steroid exposure, gestation, and recent antenatal indomethacin exposure (duration of 48 hours or more between the last dose and delivery).

Results: Fifteen retrospective cohort studies and 6 case-controlled studies met inclusion criteria. Antenatal indomethacin was associated with an increased risk of periventricular leukomalacia (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.3-3.1). Recent exposure to antenatal indomethacin was associated with necrotizing enterocolitis (OR, 2.2; 95% CI; 1.1-4.2). Antenatal indomethacin was not associated with intraventricular hemorrhage, patent ductus arteriosus, respiratory distress syndrome, bronchopulmonary dysplasia, and mortality.

Conclusion: Antenatal indomethacin may be associated with an increased risk of periventricular leukomalacia and necrotizing enterocolitis in premature infants and therefore should be used judiciously for tocolysis.

Citing Articles

Too Much of a Good Thing: Updated Current Management and Perinatal Outcomes of Polyhydramnios.

Wu F, Chen C J Med Ultrasound. 2025; 32(4):285-290.

PMID: 39801544 PMC: 11717093. DOI: 10.4103/jmu.jmu_83_24.

Risk factors and epidemiology of spontaneous intestinal perforation among infants born at 22-24 weeks' gestational age.

Thakkar P, Sutton K, Detwiler C, Henegar J, Narayan J, Perez-Romero M J Perinatol. 2023; 44(1):94-99.

PMID: 37759034 PMC: 11465378. DOI: 10.1038/s41372-023-01782-6.

Balancing Benefits and Risks of Indomethacin in the Management of Antenatal Bartter Syndrome: A Case Report.

Alajjuri O, Samaha M, Honemeyer U, Mohammed G, Mousa N Front Med (Lausanne). 2022; 9:870503.

PMID: 35847797 PMC: 9276994. DOI: 10.3389/fmed.2022.870503.

Association of Intrapartum Drugs with Spontaneous Intestinal Perforation: A Single-Center Retrospective Review.

Mantle A, Yang M, Judkins A, Chanthavong I, Yoder B, Chan B Am J Perinatol. 2021; 41(2):174-179.

PMID: 34666387 PMC: 10435317. DOI: 10.1055/a-1673-0183.

Premature closure of ductus arteriosus after a single dose of diclofenac during pregnancy.

Dos Santos C, Vaz Silva P, Castelo R, Tiago J BMJ Case Rep. 2021; 14(6).

PMID: 34167992 PMC: 8231045. DOI: 10.1136/bcr-2021-243485.

References

Vermillion S, Newman R . Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants. Am J Obstet Gynecol. 1999; 181(5 Pt 1):1083-6. DOI: 10.1016/s0002-9378(99)70085-2. View

Gleason C, Clyman R, Heymann M, Mauray F, Leake R, Roman C . Indomethacin and patent ductus arteriosus: effects on renal function in preterm lambs. Am J Physiol. 1988; 254(1 Pt 2):F38-44. DOI: 10.1152/ajprenal.1988.254.1.F38. View

Vanhaesebrouck P, Thiery M, Leroy J, Govaert P, De Praeter C, Coppens M . Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin. J Pediatr. 1988; 113(4):738-43. DOI: 10.1016/s0022-3476(88)80392-5. View

Abbasi S, Gerdes J, Sehdev H, Samimi S, Ludmir J . Neonatal outcome after exposure to indomethacin in utero: a retrospective case cohort study. Am J Obstet Gynecol. 2003; 189(3):782-5. DOI: 10.1067/s0002-9378(03)00662-8. View

Salokorpi T, Eronen M, von Wendt L . Growth and development until 18 months of children exposed to tocolytics indomethacin or nylidrin. Neuropediatrics. 1996; 27(4):174-7. DOI: 10.1055/s-2007-973782. View

Dudley D, Hardie M . Fetal and neonatal effects of indomethacin used as a tocolytic agent. Am J Obstet Gynecol. 1985; 151(2):181-4. DOI: 10.1016/0002-9378(85)90008-0. View

Vermillion S, Landen C . Prostaglandin inhibitors as tocolytic agents. Semin Perinatol. 2001; 25(4):256-62. DOI: 10.1053/sper.2001.27549. View

Moise Jr K, Huhta J, Sharif D, Ou C, Kirshon B, Wasserstrum N . Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med. 1988; 319(6):327-31. DOI: 10.1056/NEJM198808113190602. View

Hammerman C, Glaser J, Kaplan M, Schimmel M, FERBER B, Eidelman A . Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics. 1998; 102(5):E56. DOI: 10.1542/peds.102.5.e56. View

10.

Friedman S, Flidel-Rimon O, Steinberg M, Shinwell E . Indomethacin tocolysis and white matter injury in preterm infants. J Matern Fetal Neonatal Med. 2005; 18(2):87-91. DOI: 10.1080/14767050500199160. View

11.

Wurtzel D . Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function. Obstet Gynecol. 1990; 76(4):689-92. View

12.

Eronen M, Pesonen E, Kurki T, Teramo K, Ylikorkala O, Hallman M . Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr. 1994; 124(5 Pt 1):782-8. DOI: 10.1016/s0022-3476(05)81374-5. View

13.

Iannucci T, Besinger R, Fisher S, Gianopoulos J, Tomich P . Effect of dual tocolysis on the incidence of severe intraventricular hemorrhage among extremely low-birth-weight infants. Am J Obstet Gynecol. 1996; 175(4 Pt 1):1043-6. DOI: 10.1016/s0002-9378(96)80050-0. View

14.

Bustos R, Ballejo G, Giussi G, Rosas R, Isa J . Inhibition of fetal lung maturation by indomethacin in pregnant rabbits. J Perinat Med. 1978; 6(5):240-5. DOI: 10.1515/jpme.1978.6.5.240. View

15.

Major C, Lewis D, Harding J, Porto M, Garite T . Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate. Am J Obstet Gynecol. 1994; 170(1 Pt 1):102-6. DOI: 10.1016/s0002-9378(94)70392-2. View

16.

Morales W, Smith S, Angel J, OBrien W, Knuppel R . Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol. 1989; 74(4):567-72. View

17.

Norton M, Merrill J, Cooper B, Kuller J, Clyman R . Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med. 1993; 329(22):1602-7. DOI: 10.1056/NEJM199311253292202. View

18.

King J, Flenady V, Cole S, Thornton S . Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev. 2005; (2):CD001992. DOI: 10.1002/14651858.CD001992.pub2. View

19.

Andrews W, Goldenberg R, Faye-Petersen O, Cliver S, Goepfert A, Hauth J . The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. Am J Obstet Gynecol. 2006; 195(3):803-8. DOI: 10.1016/j.ajog.2006.06.083. View

20.

Papile L, BURSTEIN J, Burstein R, KOFFLER H . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978; 92(4):529-34. DOI: 10.1016/s0022-3476(78)80282-0. View